Eisai Co., Ltd. 4523.T Stock
Eisai Co., Ltd. Price Chart
Eisai Co., Ltd. 4523.T Financial and Trading Overview
Eisai Co., Ltd. stock price | 6639 JPY |
Previous Close | 9527 JPY |
Open | 9619 JPY |
Bid | 9629 JPY x 0 |
Ask | 9649 JPY x 0 |
Day's Range | 9560 - 9670 JPY |
52 Week Range | 5011 - 11250 JPY |
Volume | 2.73M JPY |
Avg. Volume | 1.66M JPY |
Market Cap | 2.76T JPY |
Beta (5Y Monthly) | 0.149425 |
PE Ratio (TTM) | 25.706049 |
EPS (TTM) | 147.74 JPY |
Forward Dividend & Yield | 160 (1.58%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 8977.5 JPY |
4523.T Valuation Measures
Enterprise Value | 2.61T JPY |
Trailing P/E | 25.706049 |
Forward P/E | 41.986397 |
PEG Ratio (5 yr expected) | 9.24 |
Price/Sales (ttm) | 3.7089632 |
Price/Book (mrq) | 3.453726 |
Enterprise Value/Revenue | 3.512 |
Enterprise Value/EBITDA | 31.969 |
Trading Information
Eisai Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.149425 |
52-Week Change | 86.47% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11250 JPY |
52 Week Low | 5011 JPY |
50-Day Moving Average | 8483.8 JPY |
200-Day Moving Average | 8061.99 JPY |
4523.T Share Statistics
Avg. Volume (3 month) | 1.66M JPY |
Avg. Daily Volume (10-Days) | 3.69M JPY |
Shares Outstanding | 286.7M |
Float | 269.21M |
Short Ratio | N/A |
% Held by Insiders | 3.43% |
% Held by Institutions | 42.83% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 160 |
Trailing Annual Dividend Yield | 1.67% |
5 Year Average Dividend Yield | 210.00% |
Payout Ratio | 0.4271 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 7.44% |
Operating Margin (ttm) | 5.61% |
Gross Margin | 76.11% |
EBITDA Margin | 10.98% |
Management Effectiveness
Return on Assets (ttm) | 2.08% |
Return on Equity (ttm) | 7.13% |
Income Statement
Revenue (ttm) | 744.4B JPY |
Revenue Per Share (ttm) | 2595.93 JPY |
Quarterly Revenue Growth (yoy) | 3.79% |
Gross Profit (ttm) | N/A |
EBITDA | 81.79B JPY |
Net Income Avi to Common (ttm) | 55.43B JPY |
Diluted EPS (ttm) | 374.62 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 267.35B JPY |
Total Cash Per Share (mrq) | 931.86 JPY |
Total Debt (mrq) | 126.11B JPY |
Total Debt/Equity (mrq) | 15.33 JPY |
Current Ratio (mrq) | 2.081 |
Book Value Per Share (mrq) | 2788.293 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1772000000 JPY |
Levered Free Cash Flow (ttm) | -49332875264 JPY |
Profile of Eisai Co., Ltd.
Country | Japan |
State | N/A |
City | Tokyo |
Address | 4-6-10, Koishikawa |
ZIP | 112-8088 |
Phone | 81 3 3817 3700 |
Website | https://www.eisai.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Q&A For Eisai Co., Ltd. Stock
What is a current 4523.T stock price?
Eisai Co., Ltd. 4523.T stock price today per share is 6639 JPY.
How to purchase Eisai Co., Ltd. stock?
You can buy 4523.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eisai Co., Ltd.?
The stock symbol or ticker of Eisai Co., Ltd. is 4523.T.
Which industry does the Eisai Co., Ltd. company belong to?
The Eisai Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Eisai Co., Ltd. have in circulation?
The max supply of Eisai Co., Ltd. shares is 287.04M.
What is Eisai Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Eisai Co., Ltd. PE Ratio is 44.93705000 now.
What was Eisai Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Eisai Co., Ltd. EPS is 147.74 JPY over the trailing 12 months.
Which sector does the Eisai Co., Ltd. company belong to?
The Eisai Co., Ltd. sector is Healthcare.
Eisai Co., Ltd. 4523.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nikkei 225 N225 | 38946.93 JPY 262.9 USD |
-0.31
|
— — | 38942.28 JPY 262.87 USD | 39346.15 JPY 265.6 USD | — - | — — |
Nikkei 300 N300 | 590.39 JPY 3.99 USD |
-0.27
|
— — | 590.19 JPY 3.98 USD | 595.76 JPY 4.02 USD | — - | — — |
- {{ link.label }} {{link}}